SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Somatogen (SMTG) -- Ignore unavailable to you. Want to Upgrade?


To: Bharat H. Barai who wrote (347)12/19/1997 10:27:00 AM
From: aknahow  Respond to of 442
 
Dr. Barai, always have appeciated your post. Owned some SMTG years ago and it was called away. At first I was disapointed but then I turned out to be lucky. Sold more Jan $5 puts today and was paid .75 for them.

Time will tell if this was a wise move or not. Must say that there appears to be a real demand for them meaning the market expects the worse for SMTG. My cost if I end up owning the stock will be $4 1/4 to $4 3/8 when yesterdays trades are included.



To: Bharat H. Barai who wrote (347)12/19/1997 8:14:00 PM
From: schadenfreude  Read Replies (1) | Respond to of 442
 
Quick story on blood substitutes in SF Chronicle. I don't know how to paste a link so I just copied and pasted it below.

sfgate.com